Open-label Trial in Parkinson's Disease (PD)
NCT04760769
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
992
Enrollment
INDUSTRY
Sponsor class
Conditions
Parkinson Disease
Interventions
DRUG:
Tavapadon
Sponsor
AbbVie